Bill > HB2270

This bill mandates that health benefit plans in Oklahoma, including the Oklahoma Employees Insurance Plan, provide coverage for specific genetic testing and cancer imaging services without imposing annual deductibles, copayments, or coinsurance limits. The bill defines key terms such as "clinical utility" (a measure of medical value), "genetic testing for an inherited mutation" (multi-gene testing for cancer risk), and "evidence-based cancer imaging" (appropriate preventative screening). Health plans must cover clinical genetic testing for individuals with a personal or family cancer history when the test is ordered by a healthcare provider and meets specific medical evidence standards, including recommendations from the National Comprehensive Cancer Network (NCCN) or other recognized clinical guidelines. Similarly, evidence-based cancer imaging for individuals at increased cancer risk must also be covered when recommended by a healthcare provider and meeting established guidelines. The bill includes a special provision for health savings accounts, ensuring compliance with federal tax code requirements while maintaining coverage for preventive care services. The new law is set to take effect on November 1, 2025, providing health insurers time to adapt to the new coverage requirements.

http://www.oklegislature.gov/BillInfo.aspx?Bill=hb2270&Session=2600